Publications by authors named "V Mankad"

Claim this Profile
L
Lower Respiratory Tract Infections Following Respiratory Syncytial Virus Monoclonal Antibody Nirsevimab Immunization Versus Placebo: Analysis From a Phase 3 Randomized Clinical Trial (MELODY).
Doug Arbetter, Vancheswaran Gopalakrishnan, Anastasia A Aksyuk, Bahar Ahani, Yue Chang, Vaishali S Mankad

Clin Infect Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps.
Brian J Lipworth, Joseph K Han, Martin Desrosiers, Claire Hopkins, Stella E Lee, Vaishali S Mankad

N Engl J Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular and phenotypic characteristics of respiratory syncytial virus isolates recovered from medically vulnerable children: An exploratory analysis of a phase 2/3 randomized, double-blind, palivizumab-controlled trial of nirsevimab (MEDLEY).
Kevin M Tuffy, Bahar Ahani, Joseph B Domachowske, Kenji Furuno, Hong Ji, Vaishali S Mankad

Vaccine· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Pharmacokinetics of Nirsevimab in Immunocompromised Children.
Joseph Domachowske, Ulrika Wählby Hamrén, Irfana Banu, Roberta Baronio, Bhanu Basavaraju, Vaishali S Mankad

Pediatrics· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Summary of Safety Data on Nirsevimab in Infants and Children from All Pivotal Randomized Clinical Trials.
Vaishali S Mankad, Amanda Leach, Yue Chang, Ulrika Wählby Hamrén, Alexandre Kiazand

Pathogens· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis